Adeno-Associated Virus (AAV) Packaging Services

AAV vectors are extensively employed for in vivo gene function studies, target validation, tumor microenvironment modulation, immunotherapy, and preclinical evaluation of gene therapy drug candidates. As a preclinical CRO dedicated to the oncology field, Alfa Cytology provides high-quality adeno-associated virus (AAV) packaging services, designed to offer safe and effective in vivo gene delivery tools for your research projects. Leveraging our state-of-the-art AAV production platform and rigorous quality control systems, our experienced scientists are committed to producing high-purity, high-titer AAV vectors tailored to meet your specific research requirements.

Introduction to Adeno-Associated Virus (AAV) Packaging

Adeno-Associated Virus (AAV) is currently one of the most widely used viral vectors in gene therapy and in vivo gene delivery. Belonging to the Parvoviridae family, AAV offers outstanding advantages including non-pathogenicity, low immunogenicity, non-integrating nature, and diverse tissue tropisms, establishing it as the gold standard for targeted in vivo gene delivery. The replication and packaging of AAV are strictly dependent on helper functions provided by co-infecting helper viruses, such as adenovirus or herpes simplex virus, a property that facilitates the production of high-purity viral preparations by effectively eliminating helper virus contamination during the manufacturing process. To date, over 12 naturally occurring AAV serotypes (AAV1–AAV12) and numerous engineered variants have been discovered or developed, each exhibiting distinct tissue tropisms—for instance, AAV9 can efficiently cross the blood–brain barrier to target the central nervous system, AAV8 displays high hepatic affinity, whereas AAV6 preferentially transduces muscle tissues. Depending on the specific tissue/organ targeting requirements, researchers can select AAV serotypes with tailored tropisms through systematic serotype screening and capsid engineering, thereby achieving efficient and precise gene delivery. By optimizing plasmid ratios in the triple-plasmid transfection system, cell culture conditions, and purification processes, robust production of high-titer, high-purity AAV preparations can be consistently attained, accommodating diverse in vivo application scenarios ranging from local injection to systemic administration.

Fig. 1 Adeno-associated virus (AAV) genome and construction of viral vectors. (Xie L, et al.; 2023)

Our Services

Leveraging a diverse AAV serotype repertoire encompassing AAV1–AAV9 and custom-engineered variants, our AAV packaging services are designed to flexibly accommodate the specific targeting requirements of various tissues and organs. Whether your research focuses on the central nervous system, hepatic metabolism, myocardial repair, retinal disorders, or the tumor microenvironment, we provide optimal serotype selection to ensure robust transduction efficiency and precise targeting in vivo.

Vector Design and Construction

Based on your research objectives, we design and construct AAV vectors carrying gene-of-interest (GOI), RNAi, or CRISPR/Cas components. Our services include:

• PCR amplification and cloning of the gene of interest.
• Promoter selection (ubiquitous / tissue-specific / inducible).
• Codon optimization (if required).
• Incorporation of fusion tags and reporter genes (GFP, mCherry, Luciferase).
• ITR integrity verification and full-length sequencing validation.

Virus Packaging and Production

Under a GMP-like quality control system, we employ a triple-plasmid co-transfection system for AAV packaging and production:

• High-quality endotoxin-free maxiprep of plasmid DNA.
• PEI-mediated co-transfection of HEK293T/HEK293 cells.
• Serum-free culture system.
• Optimized harvest and purification processes to maximize infectious particle recovery.

Virus Purification and Concentration

We utilize optimized purification procedures to ensure high purity and high infectivity of AAV:

• Iodixanol density gradient ultracentrifugation or CsCl density gradient centrifugation.
• Ion-exchange chromatography for further purification (if required).
• Ultrafiltration concentration to the desired volume.
• Effective removal of empty capsids to enhance transduction efficiency.

Quality Control Testing

Each batch of AAV is subjected to comprehensive quality control testing:

• Physical titer: qPCR for genome titer (vg/mL).
• Infectious titer: Fluorescence-based assay for infectious units (IU/mL) or TCID₅₀ method.
• Purity assessment: SDS-PAGE silver staining analysis and HPLC detection.
• Empty capsid rate: Electron microscopy or SEC-HPLC for assessment of full-to-empty particle ratio.
• Endotoxin testing: Limulus amebocyte lysate (LAL) assay (<10 EU/mL).
• Sterility testing: Bacterial, fungal, and mycoplasma detection.
• Activity validation: Verification of transgene expression in target cells.

Serotype Selection Option

We offer a comprehensive range of AAV serotype packaging services to address the targeting requirements of diverse tissues and organs, and our scientific team is available to assist with serotype screening and selection to achieve optimal transduction efficiency for your specific target tissues.

Specifications

Applications of AAV Vectors in Cancer Research

Alfa Cytology combines a state-of-the-art AAV production platform with meticulous project management and outstanding scientific expertise. Whether you are performing in vivo mechanistic studies, generating genetically engineered animal models, or advancing gene therapy candidates toward the clinic, we are your reliable partner in accelerating cancer research. Please don't hesitate to contact us to discuss your project and discover how Alfa Cytology can support your program.

For research use only.